NYSE:NCDL • US67090S1087
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUVEEN CHURCHILL DIRECT LEND (NCDL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-04 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-27 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-11-05 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-11-05 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-16 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-24 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-08 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2024-08-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-03-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-02-28 | JMP Securities | Upgrade | Market Perform -> Market Outperform |
| 2024-02-20 | Keefe, Bruyette & Woods | Initiate | Market Perform |
| 2024-02-20 | JMP Securities | Initiate | Market Perform |
| 2024-02-20 | UBS | Initiate | Neutral |
| 2024-02-20 | Wells Fargo | Initiate | Equal-Weight |
| 2024-02-20 | Truist Securities | Initiate | Buy |
| 2024-02-20 | B of A Securities | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 161.756M 96.18% | 224.04M 38.50% | 207.858M -7.22% | 186.25M -10.40% | 177.3M -4.81% | 148.76M -16.10% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 85.016M 83.53% | 123.526M 45.30% | 94.37M -23.60% | 89.015M -5.67% | 80.784M -9.25% | N/A | |
| Operating Margin | 52.56% | 55.14% | 45.40% | 47.79% | 45.56% | N/A | |
| EPS YoY % growth | N/A | 2.26 -9.56% | 1.86 -17.70% | 1.67 -10.34% | 1.54 -7.65% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.43 -18.21% | 0.42 -7.98% | 0.41 -3.93% | 0.41 -7.27% | 0.40 -8.24% | 0.40 -6.02% | 0.40 -3.70% | 0.40 -2.50% | 0.39 -1.28% | 0.39 -1.28% | 0.39 -1.28% | 0.39 -1.28% |
| Revenue Q2Q % growth | 48.634M -9.24% | 47.158M -11.24% | 45.65M -10.68% | 44.809M -10.44% | 44.325M -8.86% | 44.325M -6.01% | 44.325M -2.90% | 44.325M -1.08% | 37.103M -16.29% | 37.159M -16.17% | 37.22M -16.03% | 37.291M -15.87% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 22.685M -18.12% | 22.256M -3.59% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
12 analysts have analysed NCDL and the average price target is 15.3 USD. This implies a price increase of 16.35% is expected in the next year compared to the current price of 13.15.
NUVEEN CHURCHILL DIRECT LEND (NCDL) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of NUVEEN CHURCHILL DIRECT LEND (NCDL) is 0.43 USD and the consensus revenue estimate is 48.63M USD.
The consensus rating for NUVEEN CHURCHILL DIRECT LEND (NCDL) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.